Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO)

Q: What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q4 2023?

167 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 019770106

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 344,793,745
Total 13F shares: 122,248,338
Share change: -7,822,511
Total reported value: $392,448,357
Put/Call ratio: 614%
Price per share: $3.21
Number of holders: 167
Value change: -$24,859,731
Number of buys: 84
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 019770106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.3%	25,143,931	$79,706,262	—	30 Sep 2023	13F
TPG GP A, LLC	3/4/5 13F	10%+ Owner · Company	5.4% from 13F	18,716,306	$59,413,042	—	12 Jan 2022	3/4/5 13F
VANGUARD GROUP INC	13F	Company	3.1%	10,587,804	$33,563,338	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	2.6%	8,893,980	$28,193,917	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	2.4%	8,202,601	$26,002,245	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	2%	6,910,882	$21,907,495	—	30 Sep 2023	13F
Woodline Partners LP	13F	Company	1.5%	5,313,915	$16,845,111	—	30 Sep 2023	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.5%	5,284,386	$16,751,504	—	30 Sep 2023	13F
EcoR1 Capital, LLC	13F	Company	1.3%	4,488,200	$14,227,594	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	4,115,630	$13,046,547	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.7%	2,407,347	$7,632,000	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.6%	2,071,353	$6,567,131	—	30 Sep 2023	13F
Eric Thomas Schmidt	3/4/5	Chief Financial Officer	— mixed-class rows	2,447,772 mixed-class rows	$6,396,524	—	22 Mar 2023	3/4/5
Wildcat Capital Management, LLC	13F	Company	0.56%	1,920,787	$6,088,895	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.53%	1,838,356	$5,828,937	—	30 Sep 2023	13F
Vida Ventures Advisors, LLC	13F	Company	0.52%	1,798,163	$5,700,177	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	1,407,956	$4,463,221	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.4%	1,381,718	$4,380,045	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.38%	1,300,221	$4,121,701	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.28%	977,200	$3,097,724	—	30 Sep 2023	13F
Swedbank AB	13F	Company	0.27%	915,835	$2,903,197	—	30 Sep 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.26%	904,403	$2,866,958	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.25%	860,527	$2,727,871	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.24%	836,467	$2,651,601	—	30 Sep 2023	13F
BARCLAYS PLC	13F	Company	0.23%	786,793	$2,494,134	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	781,328	$2,476,810	—	30 Sep 2023	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.22%	764,488	$2,415,782	—	30 Sep 2023	13F
Alison Moore	3/4/5	Chief Technical Officer	— mixed-class rows	1,105,469 mixed-class rows	$2,135,517	—	22 Mar 2023	3/4/5
NORGES BANK	13F	Company	0.19%	650,072	$2,060,728	—	30 Sep 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.17%	569,955	$1,806,757	—	30 Sep 2023	13F
Veer Bhavnagri	3/4/5	General Counsel	— class O/S missing	556,049	$1,765,122	—	14 Mar 2023	3/4/5
Rafael Amado	3/4/5	EVP of R&D	— class O/S missing	541,946	$1,720,353	—	07 Oct 2022	3/4/5
CAXTON ASSOCIATES LP	13F	Company	0.14%	480,104	$1,521,930	—	30 Sep 2023	13F
PARTNERS CAPITAL INVESTMENT GROUP, LLP	13F	Company	0.13%	454,845	$1,441,859	—	30 Sep 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.12%	428,493	$1,358,322	—	30 Sep 2023	13F
Coastal Bridge Advisors, LLC	13F	Company	0.12%	406,847	$1,289,705	—	30 Sep 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.12%	400,545	$1,269,728	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	360,201	$1,141,837	—	30 Sep 2023	13F
CITIGROUP INC	13F	Company	0.1%	338,756	$1,073,857	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	326,366	$1,034,580	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.09%	310,814	$985,281	—	30 Sep 2023	13F
Rhenman & Partners Asset Management AB	13F	Company	0.09%	300,000	$951,000	—	30 Sep 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.08%	266,154	$843,708	—	30 Sep 2023	13F
Simplify Asset Management Inc.	13F	Company	0.07%	245,000	$776,650	—	30 Sep 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.07%	237,836	$753,940	—	30 Sep 2023	13F
MARSHALL WACE, LLP	13F	Company	0.07%	228,642	$724,796	—	30 Sep 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.06%	214,144	$678,836	—	30 Sep 2023	13F
UBS Group AG	13F	Company	0.06%	206,759	$655,426	—	30 Sep 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.06%	203,865	$646,252	—	30 Sep 2023	13F
Swiss National Bank	13F	Company	0.06%	192,400	$609,908	—	30 Sep 2023	13F

Institutional Holders of Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO) as of Q4 2023

As of 31 Dec 2023, Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO) was held by 167 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,248,338 shares. The largest 10 holders included FMR LLC, TPG GP A, LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, PRIMECAP MANAGEMENT CO/CA/, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, Woodline Partners LP, and STATE STREET CORP. This page lists 167 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

152

Q4 2023 holders

167

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.